Cargando…

Serum Sex Hormone Binding Globulin Concentration as a Predictor of Ovarian Response During Controlled Ovarian Hyperstimulation

Purpose: Serum concentrations of sex hormone binding globulin (SHBG), a glycated homodimeric plasma transport protein, correlate positively with the total number of follicles in women with infertility. However, the relationship between serum SHBG concentrations and the ovarian response during contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Junyu, Li, Shang, Zhu, Yinci, Sun, Yun, Chen, Zi-Jiang, Du, Yanzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600072/ https://www.ncbi.nlm.nih.gov/pubmed/34805198 http://dx.doi.org/10.3389/fmed.2021.719818

Ejemplares similares

Zinc finger gene 217 (ZNF217) Promoted Ovarian Hyperstimulation Syndrome (OHSS) through Regulating E(2) Synthesis and Inhibiting Thrombospondin-1 (TSP-1)
por: Zhai, Junyu, et al.
Publicado: (2017)

Sex Hormone-Binding Globulin (SHBG) Expression in Ovarian Carcinomas and Its Clinicopathological Associations
por: Huang, Ruixia, et al.
Publicado: (2013)

Sex hormone binding globulin measurement before conception as a predictor of gestational diabetes in women with polycystic ovarian syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2013)

Clinical application of anti-Müllerian hormone as a predictor of controlled ovarian hyperstimulation outcome
por: Lee, Jae Eun, et al.
Publicado: (2012)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Serum concentration of sex hormone-binding globulin in healthy volunteers and patients with breast cancer stratified by sex and age
por: Park, Se Jung, et al.
Publicado: (2020)

Variant-beta luteinizing hormone is not associated with poor ovarian response to controlled ovarian hyperstimulation
por: Hanevik, Hans I, et al.
Publicado: (2014)

Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia
por: Ansari, Mohammad Abdul Jalil, et al.
Publicado: (2008)

Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation
por: O’Brien, Travis J, et al.
Publicado: (2013)

Antral follicle count and anti-Müllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation
por: Izhar, Rubina, et al.
Publicado: (2021)

Is serum sex hormone-binding globulin a dominant risk factor for metabolic syndrome?
por: Yang, Yi-Hong, et al.
Publicado: (2015)

Sex Hormone-Binding Globulin in Children and Adolescents
por: Aydın, Banu, et al.
Publicado: (2016)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Preoperative Serum Sex Hormone-Binding Globulin Level Is an Independent Predictor of Biochemical Outcome After Radical Prostatectomy
por: Lee, Jung Keun, et al.
Publicado: (2015)

Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI
por: Dielen, C, et al.
Publicado: (2017)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

The Effect of Human Growth Hormone on Endometrial Growth in Controlled Ovarian Hyperstimulation Cycles
por: Bavan, Brindha, et al.
Publicado: (2022)

Relations of Insulin Resistance and Serum Concentrations of Estradiol and Sex Hormone‐binding Globulin to Potential Breast Cancer Risk Factors
por: Nagata, Chisato, et al.
Publicado: (2000)

Impact of sex hormone-binding globulin on the human phenome
por: Arathimos, Ryan, et al.
Publicado: (2020)

Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation
por: Sheikhha, Mohammad Hasan, et al.
Publicado: (2011)

Low follicular fluid tyrosine concentration in infertile women with ovarian hyperstimulation syndrome
por: AMANO, NAMIKO, et al.
Publicado: (2014)

Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study
por: Garcia-Closas, Montserrat, et al.
Publicado: (2007)

Genetic polymorphisms are associated with serum levels of sex hormone binding globulin in postmenopausal women
por: Riancho, José A, et al.
Publicado: (2008)

Relationship between de novo lipogenesis and serum sex hormone binding globulin in humans
por: Simons, Pomme I. H. G., et al.
Publicado: (2021)

Ovarian cyst regression with levothyroxine in ovarian hyperstimulation syndrome associated with hypothyroidism
por: Langroudi, Roghieh Molaei, et al.
Publicado: (2013)

The effect of controlled ovarian hyperstimulation on ovarian reserve via PTEN pathway
por: Sezginer, Perihan, et al.
Publicado: (2022)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
por: Marak, Creticus P., et al.
Publicado: (2013)

Radiological Illustration of Spontaneous Ovarian Hyperstimulation Syndrome
por: Mittal, Kartik, et al.
Publicado: (2015)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

Zika virus during controlled ovarian hyperstimulation
por: Joob, Beuy, et al.
Publicado: (2019)

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
por: Gómez, Gemma Grau, et al.
Publicado: (2019)

Low sex hormone binding globulin: a potential predictor of future glucose dysregulation in women
por: Heald, Adrian H., et al.
Publicado: (2021)

The use of gonadotropin-releasing hormone antagonist post-ovulation trigger in ovarian hyperstimulation syndrome
por: Chappell, Neil, et al.
Publicado: (2017)

Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer
por: Kojima, Nobue, et al.
Publicado: (2018)

Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome
por: Salmassi, Ali, et al.
Publicado: (2015)

Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review
por: Ingold, Caroline, et al.
Publicado: (2023)

Gender-specific associations of serum sex hormone-binding globulin with features of metabolic syndrome in children
por: Al-Daghri, Nasser M., et al.
Publicado: (2016)

The combined use of antimullerian hormone and age to predict the ovarian response to controlled ovarian hyperstimulation in poor responders: A novel approach
por: Jeve, Yadava Bapurao
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cema2qgblq5q0kkrcas33g3nv7